International Journal of Molecular Sciences: Special Issue "Advances of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)"

Sly Saint

Sly Saint

Senior Member (Voting Rights)
Deadline for manuscript submissions: 30 January 2023

Special Issue Editor
Dr. Vincent C. Lombardi E-Mail Website
SciProfiles

Guest Editor
Department of Microbiology and Immunology, School of Medicine, University of Nevada, Reno, NV, USA
Interests: Alzheimer’s disease; myalgic encephalomyelitis; microbiome; neuroimmune; plasmacytoid dendritic cell; gut-brain axis; innate immunity; interferon
Special Issue Information
Dear Colleagues,

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an illness of unknown etiology, characterized by multiple physical symptoms and comorbid conditions. Symptoms often reported by those with ME/CFS include unexplained fatigue that lasts for more than six months, post-exertional malaise, neurocognitive problems, unrefreshing sleep, and gastrointestinal issues. Clinical laboratory findings often include inflammatory sequelae, metabolic disturbances, self-reactive antibodies, and immune cell abnormalities. Although many of those who suffer from ME/CFS report that they developed the condition following a “flu-like” illness from which they never fully recover, an etiological agent has not been reproducibly identified. Likewise, many individuals infected by the SARS-CoV-2 virus often never fully recover and present with symptoms that significantly overlap with those of ME/CFS. This syndrome is typically referred to as long COVID-19 or post-acute sequelae of SARS COV-2 infection. In this Special Issue, which addresses the advances in research of myalgic encephalomyelitis/chronic fatigue syndrome, we aim to publish original research papers and reviews that focus on the involvement of the immune system in ME/CFS. Reports that leverage commonalities between ME/CFS and long COVID-19 to identify the mechanisms behind immune abnormalities are highly encouraged.

Dr. Vincent C. Lombardi
Guest Editor

Manuscript Submission Information



Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Click to expand...

https://www.mdpi.com/journal/ijms/special_issues/2UY2U938TR
 
Saw this passing again and it seems that more articles have been published since, 8 in total.

Research

Evidence of a Novel Mitochondrial Signature in Systemic Sclerosis Patients with Chronic Fatigue Syndrome, Osman et al

Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Caselli et al

Sex-Dependent Transcriptional Changes in Response to Stress in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Project, Nathanson et al

Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of ME/CFS Patients with Orthostatic Intolerance: A Pilot Study, Roy et al

Skin Temperature Circadian Rhythms and Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Role of Endothelin-1 in the Vascular Tone Dysregulation, Castro-Marrero et al

Stress-Induced Transcriptomic Changes in Females with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Reveal Disrupted Immune Signatures, Nathan et al


Review

Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Maya et al

Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID, Edgar et al
 
You must log in or register to reply here.
Back
Top Bottom